Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity
Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity
批准号:
10454041
负责人:
Ream Al-Hasani
金额:
$44.16万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2027-03-31
关键词:
ANK1 geneAffectAfferent NeuronsAnimalsAntiepileptic AgentsAutomobile DrivingBathingBehavioralBindingBiological AssayCalciumCalcium SignalingCellsChemotherapy-induced peripheral neuropathyChronicComplexDataDetectionDiagnosisElectrophysiology (science)EsthesiaEtiologyFutureGTP-Binding ProteinsGoalsHumanHypersensitivityImageIn Situ HybridizationKnock-outKnockout MiceMeasuresMechanicsMediatingModelingMultiple SclerosisMusNeuraxisNeuronsNeuropathyNon-Steroidal Anti-Inflammatory AgentsNucleus AccumbensOpioidOpioid AntagonistOpioid agonistOrgan DonorPainPathologicPatientsPeripheralPeripheral Nervous SystemPertussis ToxinPharmaceutical PreparationsPharmacologyPlatinumPlayReceptor ActivationReportingResearchRodent ModelRoleSignal TransductionSpinal GangliaStimulusSyndromeSystemTRP channelTRPA channelTailTemperatureTestingTissuesTransgenic OrganismsWild Type MouseWithdrawalallodyniabasechemotherapychronic constriction injurychronic paineffective therapyhuman tissuein vivokappa opioid receptorsnegative affectnew therapeutic targetpain patientpainful neuropathypreservationreceptorreceptor expressionrecruitside effecttherapeutic targetviral rescue
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The overall goal of this research is to better understand the how the kappa opioid receptor (KOR) system
modulates cold hypersensitivity with the ultimate goal of uncovering a novel therapeutic target. Cold pain affects
a number of diverse groups of patients and goes largely untreated. Neuropathic pain with cold allodynia is
estimated to affect 15% to 50% of neuropathic pain patients. For many patients, cold pain is often a side effect
that becomes a chronic debilitating condition. Patients undergoing chemotherapy using platinum-based drugs
report increased sensitivity and pain to cold stimuli. Furthermore, heightened sensitivity to cold is problematic in
those diagnosed with multiple sclerosis. For others, cold pain is part of larger more complex pain condition. The
most commonly reported medications used to treat neuropathic pain are non-steroidal anti-inflammatory drugs
(NSAIDs), opioids and anti-epileptics, which do not relieve or treat heightened cold sensitivity, primarily because
we do not have clear understanding of the mechanisms involved in the modulation of cold pain. This research
focuses on better understanding the mechanism by which peripheral KORs modulate cold hypersensitivity and
cold pain. The first aim of this proposal will use combined transgenic and pharmacological approaches to assess
the necessity of peripheral KOR expression in the modulation of cold hypersensitivity and cold pain. The second
aim will determine the mechanism by which KORs in dorsal root ganglion can modulate TRPA1 signaling, as
well as determine the necessity of the involvement of TRPA1 channels in KOR mediated cold hypersensitivity.
The third aim will test whether KORs in dorsal root ganglion also modulate TRPM8 signaling. In the final aim,
will use human dorsal root ganglion tissue from organ donors to determine if the KOR-modulation of TRP function
exists in humans. Together, these approaches will allow us to dissect the role of peripheral kappa opioids in cold
hypersensitivity and cold pain. Understanding the mechanisms by which the KOR system modulates cold
hypersensitivity and how this system may also be involved in modulation of cold pain will have major implications
not only in our understanding of basic mechanisms of cold hypersensitivity, but may also open up alternative
therapeutic targets to allow us to treat cold hypersensitivity and pain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity
-
批准号:10599200
-
项目类别:
-
资助金额:$42.78万
-
财政年份:2022
-
负责人:Ream Al-Hasani
-
依托单位:
Rapid and sensitive in vivo detection of opioid peptides
-
批准号:9767373
-
项目类别:
-
资助金额:$24.32万
-
财政年份:2019
-
负责人:Ream Al-Hasani
-
依托单位:
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORS
-
批准号:9766228
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2017
-
负责人:Ream Al-Hasani
-
依托单位:
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORS
-
批准号:9021634
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2015
-
负责人:Ream Al-Hasani
-
依托单位:
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORS
-
批准号:8805610
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2015
-
负责人:Ream Al-Hasani
-
依托单位:
海外基金